Correlation Between DiaMedica Therapeutics and Cingulate Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Cingulate Warrants, you can compare the effects of market volatilities on DiaMedica Therapeutics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Cingulate Warrants.

Diversification Opportunities for DiaMedica Therapeutics and Cingulate Warrants

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between DiaMedica and Cingulate is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Cingulate Warrants go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Cingulate Warrants

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.24 times more return on investment than Cingulate Warrants. However, DiaMedica Therapeutics is 4.1 times less risky than Cingulate Warrants. It trades about 0.23 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.03 per unit of risk. If you would invest  423.00  in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of  93.00  from holding DiaMedica Therapeutics or generate 21.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  Cingulate Warrants

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in January 2025.

DiaMedica Therapeutics and Cingulate Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and Cingulate Warrants

The main advantage of trading using opposite DiaMedica Therapeutics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.
The idea behind DiaMedica Therapeutics and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.